Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GDP dissociation inhibitor 2 pseudogene 1 (GDI2P1) is a non-protein-coding sequence in the human genome, located on chromosome 10. It is classified as a pseudogene, meaning it resembles the functional gene GDP dissociation inhibitor 2—an essential regulator of Rab GTPase cycling—but does not encode an active protein product. GDI2P1 is not a recognized drug target, does not have known biological functions, disease roles, or relevance for therapeutic intervention. For legitimate research, the focus should be on the protein-coding "GDP dissociation inhibitor 2 (GDI2)", which participates in vesicular trafficking and is implicated in some cancer cell death mechanisms. Confusion between pseudogenes and functional proteins is a common error in target identification and should be carefully avoided[4][8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GDP dissociation inhibitor 2 pseudogene 1 (GDI2P1).